Circulating Tumor Cells in Breast Cancer Patients : An Evolving Role in Patient Prognosis and Disease Progression

Abstract EN

In this paper, we examine the role of circulating tumor cells (CTCs) in breast cancer.

CTCs are tumor cells present in the peripheral blood.

They are found in many different carcinomas but are not present in patients with benign disease.

Recent advances in theories regarding metastasis support the role of early release of tumor cells in the neoplastic process.

Furthermore, it has been found that phenotypic variation exists between the primary tumor and CTCs.

Of particular interest is the incongruency found between primary tumor and CTC HER2 status in both metastatic and early breast cancer.

Overall, CTCs have been shown to be a poor prognostic marker in metastatic breast cancer.

CTCs in early breast cancer are not as well studied, however, several studies suggest that the presence of CTCs in early breast cancer may also suggest a poorer prognosis.

Studies are currently underway looking at the use of CTC level monitoring in order to guide changes in therapy.